Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains.

NOD mice spontaneously develop anti-insulin autoantibodies associated with the subsequent development of diabetes. NOD mice that express insulin autoantibodies at 8 weeks of age have a diabetes risk exceeding 90%, while mice that do not express autoantibodies by 16 weeks have a risk of less than 20%. NOD female mice expressed insulin autoantibodies more often than male mice (13/15+ vs. 6/15+). Autoantibodies characteristically developed between 8 and 20 weeks and then for most mice became negative at diabetes onset in NOD mice. In the diabetes-free strain NOR mice, spontaneous expression of insulin autoantibodies was observed in less mice (female 8/15+, male 3/10+) compared to NOD mice. The expression of autoantibodies was transient in NOR mice and followed the same time-course as for NOD mice and they were all negative by 28 weeks (without progression to diabetes). No correlation was found in NOR mice between the levels of autoantibodies and insulitis. The program of insulin autoantibody expression is regulated over approximately 5 months for both NOD and NOR mice with only NOD mice developing diabetes, indicating that depending upon genetic combination, the presence of insulin autoantibodies does not always predict diabetes development. In addition, this data is not consistent with the hypothesis that the time-course of autoantibodies simply reflects the destruction of beta-cells with development of diabetes.

[1]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  C. Benoist,et al.  Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes , 1999, The Journal of experimental medicine.

[3]  C. Fathman,et al.  β-Cell Destruction May Be a Late Consequence of the Autoimmune Process in Nonobese Diabetic Mice , 1996, Diabetes.

[4]  C. Benoist,et al.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Wegmann,et al.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.

[6]  R. Gill,et al.  Analysis of the spontaneous T cell response to insulin in NOD mice. , 1994, Journal of autoimmunity.

[7]  D. Wegmann,et al.  Insulin‐specific T cells are a predominant component of islet infiltrates in pre‐diabetic NOD mice , 1994, European journal of immunology.

[8]  H. Erlich,et al.  Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. , 1994, The Journal of clinical investigation.

[9]  A. Ziegler,et al.  Characterization of Insulin Autoantibodies in Relatives of Patients With Type I Diabetes , 1993, Diabetes.

[10]  G. Eisenbarth,et al.  Insulin prophylaxis in individuals at high risk of type 1 diabetes , 1993, The Lancet.

[11]  W. Frankel,et al.  NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice , 1992, Diabetes.

[12]  A. Ziegler,et al.  Life-Table Analysis of Progression to Diabetes of Anti-Insulin Autoantibody-Positive Relatives of Individuals With Type I Diabetes , 1989, Diabetes.

[13]  A. Ziegler,et al.  Concentration of Insulin Autoantibodies at Onset of Type I Diabetes: Inverse Log-Linear Correlation With Age , 1988, Diabetes Care.

[14]  G. Eisenbarth Type I diabetes mellitus. A chronic autoimmune disease. , 1986 .

[15]  M. Redondo,et al.  Commentary: Modification of the Environment Is Not the Most Efficient Way to Prevent Type 1 Diabetes , 2000 .

[16]  D. Kaufman,et al.  Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice , 1998, Diabetologia.